Welcome to our Media Center

Here in our Media Center we offer corporate press releases and other useful information for business media.


Our CEO Adityo Prakash discusses the future of #drugdesign & how subsidiary @BlockRulesLtd is reshaping… twitter.com/i/web/status/1…
12 Feb
Really enjoyed Patrick Lyden's William M Feinberg Award talk a few days ago at #ISC19. Great overview of the develo… twitter.com/i/web/status/1…
9 Feb
Yesterday Maurizio Paciaroni highlighted recent advances in #stroke prevention at #ISC19. But, there is still room… twitter.com/i/web/status/1…
8 Feb
One of our researchers presenting new data on our new PRecision Oral Anticoagulants at #ISC19 pic.twitter.com/1N2eR97m8M
8 Feb
RT @PharmSource: .@VerseonCorp initiates patient dosing in a Phase I trial in Australia with VE-1902 for the prevention of stroke and heart…
8 Feb

Proprietary Platform

Consistently designs novel drug candidates that are unlikely to be found using conventional methods


Drug Programs

Multiple therapeutic areas, all with unmet (or poorly met) medical needs